pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE
NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE (NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE)
no indication
ALMATICA
NITROGEN
NITROGEN
no indication
LINDE NORTH AMERICA INC
Preclinical
NIV-001
Stroke
Neuro-Innovators LLC
NIVESTYM
NIVESTYM (FILGRASTIM-AAFI)
← prev
page 130 of 271
next →
Pain
89
Neurology
1
no indication
Hospira Inc
Phase 1
NKT-3964
Adenocarcinoma Of The Gastroesophageal Junction
NiKang Therapeutics Inc
Phase 1
NLX-101
Fragile X Syndrome
Neurolixis Inc
Preclinical
NM-1014
Autism Spectrum Disorder (ASD)
Nova Mentis BioTech Corp
Preclinical
NM-1020
Fragile X Syndrome
Nova Mentis BioTech Corp
Phase 1
NM-5072
Paroxysmal Nocturnal Hemoglobinuria
NovelMed Therapeutics Inc
Phase 1
NM-6603
Colorectal Cancer
Nucmito
Phase 2
NMDP-02
ignaseclant
Spinal Muscular Atrophy (SMA)
NMD Pharma AS
Phase 2
NMDP-08
ignaseclant
Charcot-Marie-Tooth Disease Type I
NMD Pharma AS
Phase 1
NMS-812
Refractory Acute Myeloid Leukemia
Nerviano Medical Sciences SRL
Phase 1
NN-3201
Adenoid Cystic Carcinoma (ACC)
Novelty Nobility Inc
Preclinical
NNDA-001
Parkinson's Disease
Neoneuron LLC
Preclinical
NNI-351
Fragile X Syndrome
NeuroNascent Inc
Phase 1
NNI-362
Alzheimer's Disease
NeuroNascent Inc
Phase 1
NO-13065
Obesity
Otsuka Pharmaceutical Co Ltd
Preclinical
NOD-2
Unspecified Cancer
Nodus Oncology Ltd
Preclinical
NOD-800
Geographic Atrophy
Nanoscope Therapeutics Inc
NORELGESTROMIN AND ETHINYL ESTRADIOL
NORELGESTROMIN AND ETHINYL ESTRADIOL
no indication
ZYDUS PHARMS
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE)
no indication
Baxter Healthcare Corp
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE (NOREPINEPHRINE BITARTRATE)
no indication
Sagent Pharmaceuticals Inc
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
no indication
GLENMARK PHARMS LTD
NORGESIC
NORGESIC (ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE)
no indication
GALT PHARMS
NORGESTIMATE AND ETHINYL ESTRADIOL
NORGESTIMATE AND ETHINYL ESTRADIOL (ETHINYL ESTRADIOL)
no indication
Mylan Pharmaceuticals Inc
NORMOSOL-R
NORMOSOL-R (SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE)
no indication
OTSUKA ICU MEDCL
Preclinical
NOS-01
Phelan-McDermid Syndrome (22q13.3 Deletion Syndrome)
Nospharma
Phase 2
NOUS-209
Gastric Cancer
Nouscom AG
Phase 1
NOVA-1010
Schizophrenia
Novastage Pharmaceuticals (Shenzhen) Ltd
